JACQUELYN PLICK: Open Payments
NPI 1609026665 · NEW BRUNSWICK, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$972 in 32 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $104 · 2025 $972
Food & beverage: $972
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 7 | $285 |
| Tandem Diabetes Care, Inc. | 1 | $206 |
| Insulet Corporation | 9 | $168 |
| Novo Nordisk Inc | 3 | $64 |
| Corcept Therapeutics | 2 | $47 |
| Madrigal Pharmaceuticals | 2 | $45 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $43 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $23 |
| Amgen Inc. | 1 | $22 |
| CeQur Corporation | 1 | $18 |
Products named: MINIMED 780G, t:slim X2 Insulin Pump with Control-IQ, Omnipod, Korlym, REZDIFFRA, Kerendia, Ozempic, JARDIANCE.
Industry payments across NJ — which companies pay providers there.
